Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Developed by Northwestern Engineering’s Igor Efimov and George Washington University’s Luyao Lu, the implantable device uses ...

Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your heart health at home. Here are the tools they suggest (and who they most ...

The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of the device. CEO Scott Whitaker said “an exemption was provided for most ...